BALA CYNWYD, PA--(Marketwire - October 18, 2007) - Duska Therapeutics, Inc. (“Duska” or the “Company”) (OTCBB: DSKA), a biopharmaceutical company developing new medicines to treat cardiovascular diseases, announced today the appointment of Shepard M. Goldberg and Steven Dinh, Sc.D., as board directors.
